4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings

Published: Jul 17, 2017

Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson & Johnson reporting second quarter results tomorrow before the market opens. Swiss pharma giant, Novartis, which was in the news recently related to a favorable FDA advisory panel recommendation for its CAR-T cell therapy, will also be reporting second quarter results tomorrow.

Back to news